Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02774681
Title Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

Her2-receptor positive breast cancer

Therapies

Trastuzumab

Palbociclib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern University Chicago Illinois 60611 United States Details
Northwestern Lake Forest Hospital Lake Forest Illinois 60045 United States Details
Houston Methodist Hospital/Houston Methodist Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field